Observing outcomes of high-precision radiotherapy in metastatic breast cancer
Prospective Observational Study on Outcome of High-precision Hypo-fractionated Radiotherapy in Metastatic Breast Cancer (PRECISE-M)
This study looks at how well high-precision radiation treatments work for people with metastatic breast cancer who have already had or are about to receive advanced radiation therapies.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 400 (estimated) |
| Ages | 19 Years to 100 Years |
| Sex | Female |
| Sponsor | Samsung Medical Center Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Seoul) |
| Trial ID | NCT05907681 on ClinicalTrials.gov |
What this trial studies
This study observes the outcomes of high-precision hypo-fractionated radiotherapy in patients with metastatic breast cancer. It focuses on individuals who have undergone or are scheduled to receive advanced radiation therapies such as IMRT, SBRT, or proton therapy. The study aims to gather data on the effectiveness and safety of these treatment approaches in managing distant metastasis in breast cancer patients.
Who should consider this trial
Good fit: Ideal candidates for this study are patients with histologically confirmed breast cancer who have distant metastasis and are undergoing high-precision radiation therapy.
Not a fit: Patients who are unable to adhere to the study protocol will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into optimizing radiotherapy for patients with metastatic breast cancer, potentially improving treatment outcomes.
How similar studies have performed: While this approach is observational, similar studies have shown promising outcomes with high-precision radiotherapy techniques in cancer treatment.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * histologically confirmed breast cancer * presence of distant metastasis * radiation therapy using IMRT, SBRT, or proton therapy is done or planned * Able and willing to comply with the study protocol Exclusion Criteria: * unable to adhere to the study protocol
Where this trial is running
Seoul
- Samsung Medical Center — Seoul, South Korea (Recruiting)
Study contacts
- Principal investigator: Haeyoung Kim — Samsung Medical Center
- Study coordinator: Haeyoung Kim
- Email: haeyoung0131.kim@samsung.com
- Phone: +82-02-3410-2612
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.